Christophe van Huffel
Directeur/Bestuurslid bij StratiCELL SA
Oorsprong van het eerstegraads netwerk van Christophe van Huffel
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
StratiCELL SA
 StratiCELL SA Miscellaneous Commercial ServicesCommercial Services StratiCELL SA provides vitro testing services. Its dermo cosmetic testing services include gene expression profiling, in virto bioassays, safety and dermal toxicology, percutaneous absorption and customized research and development partnership. The company was founded by Michel Salmon and Olivier Toussaint in 2005 and is headquartered in Les Isnes, WA.
14
| Holding Company | Miscellaneous Commercial Services | 14 |
Puilaetco
7
| Extinct | Investment Banks/Brokers | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Christophe van Huffel via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| SANOFI | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| TIGENIX NV | Medical Specialties | Corporate Officer/Principal | |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts. | Investment Managers | Private Equity Investor | |
| CROSSJECT | Medical Specialties | Director/Board Member | |
EURALIS Holding SA
 EURALIS Holding SA Food: Meat/Fish/DairyConsumer Non-Durables EURALIS Holding SA produces agricultural and food products. It produces, collects and markets foie gras, cereals, poultry, ducks, oil protein crops, vegetables, and others, agricultural and general public distribution of garden centres, pet shops and local food products. The company was founded in 1936 and is headquartered in Lescar, France. | Food: Meat/Fish/Dairy | Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin | |
| KBC GROUPE NV | Regional Banks | Director/Board Member | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Director/Board Member | |
| Université Libre de Bruxelles | College/University | Doctorate Degree Corporate Officer/Principal | |
| Facultés Universitaires Notre-Dame de la Paix | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Université Catholique de Louvain | College/University | Undergraduate Degree | |
Apitope International NV
 Apitope International NV BiotechnologyHealth Technology Apitope International NV develops therapeutic vaccines. It operates as a bio-pharmaceutical company that engages in developing peptide therapies. The firm specializes on the discovery and development of revolutionary disease modifying therapies for treating autoimmune and allergic diseases, including multiple sclerosis, and Graves’ disease, FVIII intolerance and uveitis. The company was founded by David Wraith in 2002 and is headquartered in Diepenbeek, Belgium. | Biotechnology | Chief Operating Officer | |
Apitope Technology (Bristol) Ltd.
 Apitope Technology (Bristol) Ltd. Miscellaneous Commercial ServicesCommercial Services Apitope Technology (Bristol) Ltd. is a European biotech company developing therapeutic vaccines for treating autoimmune and allergic diseases, including multiple sclerosis, Type 1 diabetes, Graves' disease, allergies and organ transplant rejection. The team at Apitope is developing potential therapies intended to selectively treat the underlying cause of a range of autoimmune diseases rather than simply treat the disease symptoms or non-specifically suppress the whole immune system. Apitope's approach is based on well-established scientific evidence published in leading scientific journals showing that soluble, synthetic peptides can selectively suppress abnormal immune responses and reinstate the normal immune balance and thereby, tolerance. The firm's strategy is to position itself as a significant player in the therapeutic peptide space and make it a partner of choice for pharmaceutical companies keen to develop disease modifiers for autoimmune conditions. It has a highly experienced senior management team, with a proven track record in discovering and developing innovative compounds. The company's lead product candidate is under investigation for the potential treatment of multiple sclerosis and is currently in Phase I clinical development. It is partnered with Merck-Serono (a division of Merck KGaA, Darmstadt, Germany), one of the leading companies in the development and marketing of MS therapies. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PLANT ADVANCED TECHNOLOGIES | Chemicals: Specialty | Chief Executive Officer Director of Finance/CFO Founder Director/Board Member | |
| Cera Beheersmaatschappij NV | Director/Board Member | ||
| Wageningen University | College/University | Doctorate Degree | |
WOW Company International SA
 WOW Company International SA Miscellaneous ManufacturingProducer Manufacturing WOW Company International SA develops and distributes wave generators. The company was founded by Joël Demarteau and is headquartered in Naninne, Belgium. | Miscellaneous Manufacturing | Founder | |
| Pau Seeds, Inc. | President | ||
| Institut Supérieur d'Agriculture de Lille | College/University | Corporate Officer/Principal | |
| Pau Semillas SA | President | ||
| King, Inc. | Chief Tech/Sci/R&D Officer | ||
| Université de Lorraine | College/University | Director/Board Member | |
Couleurs de Plantes SAS
 Couleurs de Plantes SAS Chemicals: SpecialtyProcess Industries Couleurs de Plantes SAS operates as an agro industrial company. The firm manufactures dye-plant extracts, plant dyes and natural dyes, plant pigments and plant lakes, inks and other coloring matter from plants. The company was founded in 2005 and is headquartered in Rochefort, France. | Chemicals: Specialty | Chairman | |
NEOMED-LABS, Inc.
 NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology NEOMED-LABS, Inc. engages in operation of a contract research organization. It offers clinical immunology laboratory services. The company was founded by Max Fehlmann in March 4, 2015 and is headquartered in Montréal, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
Pacific Biomarkers, Inc.
 Pacific Biomarkers, Inc. Medical SpecialtiesHealth Technology Pacific Biomarkers, Inc. provides biomarker testing services. The firm is a service provided supporting pharmaceutical, biotech and in-vitro diagnostic (IVD) manufacturing companies through preclinical and Phase I-IV studies of drug and IVD development. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | Medical Specialties | Chief Executive Officer | |
Nexelis Laboratories Canada, Inc.
 Nexelis Laboratories Canada, Inc. BiotechnologyHealth Technology Laboratoires Nexelis Canada, Inc. develops immunology evaluation for vaccine and immunotherapy. It offers protein services, immunochemistry, and bioanalytical services. The company was founded by Danielle Poirier in 1989 and is headquartered in Laval, Canada. | Biotechnology | Chief Executive Officer | |
| L'école Nationale Supérieure En Génie Des Systèmes Et De L'Inn | Director/Board Member | ||
| Cellengo | Chief Executive Officer | ||
| Quantitatis SARL | Corporate Officer/Principal Corporate Officer/Principal |
Statistieken
Internationaal
| Frankrijk | 14 |
| België | 10 |
| Verenigde Staten | 4 |
| Canada | 4 |
| Nederland | 3 |
Sectoraal
| Health Technology | 11 |
| Consumer Services | 8 |
| Finance | 3 |
| Commercial Services | 3 |
| Process Industries | 3 |
Operationeel
| Director/Board Member | 19 |
| Corporate Officer/Principal | 18 |
| Analyst-Equity | 7 |
| Chief Executive Officer | 6 |
| Chief Tech/Sci/R&D Officer | 5 |
Sterkste connecties
- Beurs
- Insiders
- Christophe van Huffel
- Bedrijfsconnecties
